1. Availability of anticancer biosimilars in 40 countries. Issue 2 (February 2020) Authors: Huang, Hui-Yao; Wu, Da-Wei; Ma, Fei; Liu, Zhi-Lei; Shi, Ju-Fang; Chen, Xia; Wang, Shu-Hang; Fang, Hong; Bai, Ying; Yu, Yue; Fang, Yuan; Sun, Chao; Fan, Qi; Wu, Ying; Fan, Rui-Hua; Zhou, Cai-Yun; He, Bao-Xia; Dai, Min; Li, Ning; Xu, Bing-He Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review. Issue 11 (November 2019) Authors: Li, Ning; Huang, Hui-Yao; Wu, Da-Wei; Yang, Zhi-Min; Wang, Jun; Wang, Jian-Sheng; Wang, Shu-Hang; Fang, Hong; Yu, Yue; Bai, Ying; Yan, Zhao; Cao, Ye; Jiang, Min; Liu, Yan-Fei; Li, Kun-Yan; Xu, Bing-He; Sun, Yan; He, Jie Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: e619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical development of immuno-oncology in China. Issue 8 (August 2020) Authors: Wu, Da-Wei; Huang, Hui-Yao; Tang, Yu; Zhao, Yang; Yang, Zhi-Min; Wang, Jun; Wang, Shu-Hang; Yu, Yue; Fang, Yuan; Fang, Hong; Bai, Ying; Sun, Chao; Fan, Qi; Yu, An-Qi; Wang, Huan-Ling; Du, Chun-Xia; Chen, Kun; Huang, Ming-De; Zhang, Yin; Li, Ning Journal: Lancet oncology Issue: Volume 21:Issue 8(2020) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21. Issue 1 (December 2016) Authors: Yu, Jiang-Yong; Yu, Si-Fan; Wang, Shu-Hang; Bai, Hua; Zhao, Jun; An, Tong-Tong; Duan, Jian-Chun; Wang, Jie Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Landscape and progress of global COVID-19 vaccine development. Issue 10 (3rd October 2021) Authors: Huang, Hui-Yao; Wang, Shu-Hang; Tang, Yu; Sheng, Wei; Zuo, Chi-Jian; Wu, Da-Wei; Fang, Hong; Du, Qiong; Li, Ning Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 10(2021) Page Start: 3276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling. (November 2022) Authors: Chen, Xin-Sen; Wang, Shu-Hang; Liu, Chen-Yan; Gao, Yu-Lei; Meng, Xiang-Long; Wei, Wei; Shou, Song-Tao; Liu, Yan-Cun; Chai, Yan-Fen Journal: Pharmacological research Issue: Volume 185(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗